subsistence and Drug Administration...

subsistence and Drug Administration officials want to knob development of new medical products--which has been in the doldrums lately--and also obtain information to enhance the safe use of approved therapies. To this [i]finale[/i] FDA commissioner Mark McClellan is backing a number of agency efforts to clarify regulatory requirements and streamline oversight to facilitate clinical research and avoid unnecessary data collection. tonic initiatives include overhauling 21 CFR 11 promoting pediatric studies, and clarifying standards for measuring patient/subject reported issues

Back to the